PAC8 is a venture capital firm that invests in disruptive technology platforms and healthcare companies. PAC8 focuses on seed stage investments, primarily in the US market.

PAC8

Pacific 8 Ventures is a venture capital firm that invests at the nexus of cutting-edge technology platforms and biology/medicine. We focus on early-stage startups.

Our investments consist of high-performing companies in the area of synthetic biology, gene therapy, CRISPR, machine learning/artificial intelligence, digital therapeutics, and more.

Founders appreciate that we can be more than just a capital partner but also a strategic partner for market access given our LP and advisor base consists of groups that own and operate hospitals, clinics, health insurance, and life insurance companies.

Pacific 8 Ventures

Congratulations to Ashley Zehnder and the Fauna Bio team on being chosen from hundreds of nominees for Fierce Biotech’s 2024 Fierce 15 List! This fantastic recognition shines a spotlight on their innovative approach in harnessing the power of biology from other species to advance human health. Keep up the amazing work!

Congratulations to Empirical Health for launching Empirical 2.0, which integrates biometric data with medical AI to provide personalized healthcare!!!

Huge congratulations to Oguzhan Atay, PhD, David Tsao, and the exceptional BillionToOne team on securing $130 million in an oversubscribed Series D funding round. This funding will further revolutionize the prenatal screening and oncology diagnostics landscape.

We’re incredibly proud of the team and thrilled to have partnered with them on this exciting journey!!!

Congratulations to Trevor Martin, Janice Chen, Lucas Harrington and the Mammoth Biosciences team for securing another major gene-editing collaboration with Regeneron! This $100M upfront agreement is poised to develop in-vivo CRISPR-based gene editing therapies, broadening their potential to target various tissues beyond the liver. What an incredible achievement!!!

Metric
Company Name	PAC8
Symbol
MSH ID	COM:PAC8
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	3
Website	pac8.com
LinkedIn	pac8
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PAC8

COM:PAC8

PAC8

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue